Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla
Introduction
l-glutamate is the major excitatory neurotransmitter in mammalian brain. Besides, it is involved in protein and fatty acid synthesis in brain. As the influx of glutamate across the blood–brain barrier is much lower than its efflux (Palmada and Centelles, 1998), glutamate metabolism itself is decisive for glutamate regulation in the brain. Among the precursors and reaction products of the glutamate system, glutamine plays a major part, besides α-ketoglutarate and γ-aminobutyric acid (GABA). Given the importance of glutamate and the diversity of the enzyme systems involved and of the associated membrane receptors and their regulators Danboldt, 2001, Palmada and Centelles, 1998, Ross, 1991, it is not surprising that the glutamate system plays an emerging role in the study of psychiatric disorders, such as epilepsy Petroff et al., 1995, Petroff et al., 2002, Simister et al., 2003, schizophrenia Bartha et al., 1997, Bartha et al., 1999, Kegeles et al., 2000, Théberge et al., 2002, and affective disorders Auer et al., 2000, Pfleiderer et al., 2003, and elements of this system might be identified as targets for novel drugs against such disorders Goff and Coyle, 2001, Ketter and Wang, 2003, Krystal et al., 2002. Consequently, practical and reliable methods for the in vivo quantification of glutamate in the relevant brain regions are required.
Owing to its molecular structure, glutamate (Glu) gives rise to a complex proton NMR spectrum characterized by the coupled spins of the C2–C4 hydrogen nuclei. At the moderate but prevalent field strength of 1.5 T, the in vivo brain spectrum in the respective spectral ranges exhibits poor resolution and, despite the relatively high Glu concentration of 7–12 mmol/l (see below), low sensitivity due to heavy overlap and rapid dephasing of the multiplets. Primary approaches to the in vivo detection of the coupled spin system of Glu have relied on the acquisition of spin echoes or stimulated echoes using short echo times, targeting at the C4 proton multiplet resonance around 2.35 ppm. Although keeping signal losses due to J-modulation low, such spectra suffer from substantial contributions by glutamine as well as ill-defined background features. In conventional spin echo spectroscopy at 1.5 T, the resonances in this range are therefore mostly assigned to a mixture of Glu and glutamine (and sometimes GABA), designated Glx. Glutamate determination using MRS at higher B0, such as 4 T Kassem and Bartha, 2003, Théberge et al., 2002 or 7 T (Tkač et al., 2001) may lead to higher selectivity and accuracy but is usually unavailable to a wider range of users. Spectral editing methods for Glu making use of higher magnetic field strengths to decrease the effects of strong coupling have also been devised Lee et al., 1995, Pan et al., 1996, Thompson and Allen, 1998. Though having the potential of good background suppression and fair glutamine separation, the promising multiple quantum coherence filter operated at 3 T devised by Thompson and Allen (1998) is limited by its low efficiency which requires long acquisition times. However, with the increasing availability of 3 T scanners in research and clinical facilities the implementation of an arsenal of methods truly exploiting that field strength becomes highly desirable, including reliable spectroscopy beyond the usual singlets of N-acetylaspartate (NAA), creatine + creatine phosphate (tCr), and choline-containing compounds (tCho). Thus, a promising method for GABA measurement at 3 T has recently been proposed, offering a solution to the problem of the glutamate multiplet interfering with the GABA target resonance around 2.3 ppm (Hanstock et al., 2002).
The present work aims at the development of a method for quantitative determination of the glutamate (Glu) concentration in human brain using single voxel MR spectroscopy at 3 T that would be reasonably selective and at the same time practical and reliable in the clinical setting. To this end, conventional point resolved spectroscopy (PRESS) was optimized at 3 T; complementarily the above-mentioned multiple quantum filter sequence for glutamate (Thompson and Allen, 1998) was modified and implemented, and its performance for glutamate measurement in brain compared with that of the former method. For quantification a newly developed, versatile time domain-frequency domain method of data analysis involving prior knowledge obtained from phantom spectra was employed for both types of in vivo spectra. This method package was applied to the repeat study of two important cortical voxels, namely the anterior cingulate and the left hippocampus, in 40 healthy volunteer brains to create a database of glutamate concentrations for forthcoming studies, for example, of psychiatric disorders. Since the PRESS method also provides the concentrations of the principal MRS-visible metabolites NAA, tCr, and tCho as well as an estimate of the glutamine level, these parameters were included in the analysis.
Section snippets
Subjects
Forty healthy volunteers (20 females, 20 males, aged 20–60 years, 36 ± 10 years) were recruited through advertisement in the local press. All subjects gave written informed consent. The study was approved by the ethics committee of the University Hospital Benjamin Franklin, Free University of Berlin (Germany). The participants were interviewed by a research psychiatrist with structured clinical interviews (M.I.N.I.) (Sheehan et al., 1998). Exclusion criteria were axis-I or axis-II disorders,
Results
Transverse relaxation times (in ms, SD in parentheses) of Glu, NAA, tCr and tCho determined from three subjects were for the acc voxel: 194 (37), 278 (31), 179 (9), 282 (45); and for the hc voxel: 171 (22), 267 (15), 198 (31), 291 (13). Note that for Glu, these are effective rather than true T2 values since they were determined by referencing to phantom spectra acquired at the same echo times. The mean values were used for metabolite quantification.
Fig. 2 depicts in vivo PRESS spectra acquired
Discussion
The aim of the present work was to develop and validate a method to determine the concentration of glutamate in human brain by proton MRS. From a study of the dependence of the spectral pattern on echo time, it can be concluded that PRESS using TE = 80 ms provides a good tool for Glu spectroscopy in vivo at 3 T. Compared to dedicated glutamate editing pulse sequences, it appears no less sensitive and selective but gives the added value of permitting to determine the three main singlet
Acknowledgements
The help of Clemens Elster and Monika Walzel with the calculation of uncertainties is gratefully acknowledged.
References (50)
- et al.
Multimodal image coregistration and partitioning—A unified framework
NeuroImage
(1997) - et al.
Voxel-based morphometry—The methods
NeuroImage
(2000) - et al.
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study
Biol. Psychiatry
(2000) - et al.
Regional distribution of glutamate and aspartate in adult and old human brain
Brain Res.
(1992) - et al.
A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients
Biol. Psychiatry
(1999) In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T
J. Magn. Reson.
(1999)- et al.
Comparison of time domain and time domain frequency domain methods using a novel test procedure
Magn. Reson. Imaging
(2000) - et al.
Application of LCModel for quality control and quantitative in vivo 1H MR spectroscopy by short echo time STEAM sequence
Magn. Reson. Mat. Physiol. Biol. Med.
(2000) - et al.
Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies
Psychiatry Res.
(2000) - et al.
Reproducibility of metabolite peak areas in 1H MRS of brain
Magn. Reson. Imaging
(1996)
In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia
Biol. Psychiatry
Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain
Magn. Reson. Imaging
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients
Psychiatry Res.
Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations
Magn. Reson. Mat. Physiol. Biol. Med.
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach
Magn. Reson. Med.
Single-voxel proton MRS of the human brain at 1.5 T and 3.0 T
Magn. Reson. Med.
Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy
Arch. Gen. Psychiatry
Reproducibility of 1H-MRS in vivo
Magn. Reson. Med.
Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times
Magn. Reson. Med.
Glutamate uptake
Prog. Neurobiol.
Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites
NMR Biomed.
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
Am. J. Psychiatry
Localized 13C NMR spectroscopy in the human brain of amino acid labeling from d-[1–13C]glucose
J. Neurochem.
GABA X2 multiplet measured pre- and post-administration of vigabatrin in human brain
Magn. Reson. Med.
Development and aging of the cerebrum: assessment with proton MR spectroscopy
AJNR Am. J. Neuroradiol.
Cited by (241)
Relationships between GABA, glutamate, and GABA/glutamate and social and olfactory processing in children with autism spectrum disorder
2023, Psychiatry Research - NeuroimagingTestosterone administration affects <sup>1</sup>H-MRS metabolite spectra in transgender men
2023, PsychoneuroendocrinologyThe relationship between glutamate and resting-state connectivity in chronic cannabis users
2023, Cannabis Use, Neurobiology, Psychology, and TreatmentMonte Carlo study of metabolite correlations originating from spectral overlap
2022, Journal of Magnetic ResonanceAssociation between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder
2022, European Neuropsychopharmacology